Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Neoplasms 1 Neoplasm Metastasis 1 Lymphoma 1 Lung Neoplasms 1 Cholangiocarcinoma 1 Central Nervous System Neoplasms 1 Carcinoma, Small Cell 1 Brain Neoplasms 1

Interventions

pembrolizumab 30 Capecitabine 24 Bevacizumab 23 Cyclophosphamide 22 Gemcitabine 21 Paclitaxel 20 Nivolumab 19 Fluorouracil 19 Docetaxel 18 aldesleukin 17 Leucovorin 17 Irinotecan 17 Oxaliplatin 15 Interleukin-2 14 Radiosurgery 13 Cisplatin 13 Cetuximab 13 fludarabine 12 Carboplatin 12 Albumin-Bound Paclitaxel 11 fludarabine phosphate 10 Ipilimumab 10 Drug Therapy 10 Doxorubicin 10 Sunitinib 9 Radiotherapy 9 Everolimus 9 130-nm albumin-bound paclitaxel 9 Trastuzumab 8 Temozolomide 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Neoplasm Metastasis × RRx-001 × Clear all

NCT02801097 2022-05-17

PAYLOAD

EpicentRx, Inc.

Phase 1 Terminated

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡